Zydus launches VaxiFlu vaccine for flu protection
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Replicate will receive research funding and could potentially receive up to approximately US$550 million
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The complex four-hour surgery was performed by a multidisciplinary team of doctors
The company has improved access to quality healthcare for seniors across both urban and rural areas
Subscribe To Our Newsletter & Stay Updated